Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV)

Historical Holders from Q4 2021 to Q3 2025

Symbol
ROIV on Nasdaq
Type / Class
Equity / Common Shares, par value $0.0000000341740141 per share
Shares outstanding
695,088,397
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
501,588,812
Holdings value
$7,588,880,378
% of all portfolios
0.016%
Number of holders
331
Number of buys
181
Number of sells
-153
Average buys %
+0%
Average sells %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ramaswamy Vivek 11.63% +3.9% $913,351,307 +$11.01 82,956,522 +0% Ramaswamy Vivek 31 Mar 2025
FMR LLC 8.2% $602,830,791 55,509,280 FMR LLC 30 Jun 2025
SB INVESTMENT ADVISERS (UK) LTD 5.8% -30% $609,967,872 -$328,962,663 40,315,127 -35% SB Investment Advisers (UK) Limited 30 Sep 2025
MORGAN STANLEY 5.5% $408,842,901 37,646,676 Morgan Stanley 30 Jun 2025
QVT Financial LP 4.3% -54.7% $319,084,556 -$395,435,884 29,381,635 -55.3% QVT Financial LP 30 Jun 2025
VIKING GLOBAL INVESTORS LP 3.4% -32.4% $356,989,793 -$161,027,803 23,594,831 -31.1% VIKING GLOBAL INVESTORS LP 30 Sep 2025

Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 501,588,812 $7,588,880,378 -$163,254,242 $15.13 331
2025 Q2 514,772,354 $5,801,411,223 -$418,510,172 $11.27 337
2025 Q1 553,328,719 $5,583,781,669 -$111,475,682 $10.09 310
2024 Q4 562,446,665 $6,653,171,538 -$86,396,710 $11.83 312
2024 Q3 569,136,749 $6,567,461,922 +$223,573,966 $11.54 291
2024 Q2 546,001,457 $5,771,073,920 +$151,629,366 $10.57 293
2024 Q1 531,561,894 $5,603,149,203 -$165,817,358 $10.54 258
2023 Q4 541,631,584 $6,081,436,620 -$171,734,221 $11.23 223
2023 Q3 545,872,779 $6,375,349,918 +$537,705,852 $11.68 205
2023 Q2 497,346,775 $5,012,967,398 +$397,737,203 $10.08 178
2023 Q1 459,356,125 $3,389,932,964 +$349,480,110 $7.38 144
2022 Q4 411,727,361 $3,289,525,255 +$291,883,961 $7.99 107
2022 Q3 370,512,297 $1,192,938,093 +$30,768,202 $3.22 75
2022 Q2 360,483,554 $1,467,028,314 +$45,607,814 $4.07 71
2022 Q1 349,161,599 $1,724,680,470 +$48,168,384 $4.94 50
2021 Q4 339,213,133 $3,416,732,000 +$3,374,253,000 $10.08 40